BFM
CHRS icon

Boothbay Fund Management’s Coherus Oncology CHRS Stock Holding History

Boothbay Fund Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-144
Closed -$234K – 988
2020
Q1 		$234K Hold
144
– – 0.02% 629
2019
Q4 		$259K Buy
+144
New +$2.66K 0.02% 630
2019
Q3 		– Sell
-193
Closed -$427K – 779
2019
Q2 		$427K Buy
+193
New +$3.35K 0.04% 455

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Boothbay Fund Management's CHRS Position: Q2 2026 in Review

Boothbay Fund Management held its Coherus Oncology (CHRS) position steady in Q2 2026 at 15,287 shares worth $21.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2156.

Boothbay Fund Management first reported a position in CHRS in Q2 2019 and has held it in 16 quarters since. The position peaked at $761K in Q2 2019. 146 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • Boothbay Fund Management held 15,287 shares of Coherus Oncology worth $21.4K as of Q2 2026.
  • Boothbay Fund Management left its Coherus Oncology share count unchanged in Q2 2026.
  • Coherus Oncology made up ﹤0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #2156 holding.
  • Boothbay Fund Management first reported a position in Coherus Oncology in Q2 2019 and has held it in 16 quarters since.
  • Boothbay Fund Management's Coherus Oncology position peaked at $761K in Q2 2019.
  • 146 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.